| 1. | KRAUWINKEL, W., Astellas Pharma Europe, Țările de Jos (Olanda), NOUKENS, J., Kinesis Pharma BV, Țările de Jos (Olanda), VAN DIJK, J., Astellas Pharma Europe, Țările de Jos (Olanda), POPA, S., dr., OUATAS, T., Astellas Pharma Europe, Țările de Jos (Olanda), DE VRIES, M., Astellas Pharma Europe, Țările de Jos (Olanda), PHUNG, D., Astellas Pharma Europe, Țările de Jos (Olanda), GIBBONS, J., Medivation, Inc, Statele Unite ale Americii, MORDENTI, J., Medivation, Inc, Statele Unite ale Americii, MATEVA, L., Gastroenterology Clinic, University Hospital St. Ivan Rilski, Medical University Sofia, Bulgaria A comparison of the pharmacokinetics and safety of enzalutamide in subjects with hepatic impairment and matched healthy subjects. Journal of Clinical Pharmacy and Therapeutics. 2017, nr. , 275-268. ISSN 0269-4727 ISSNe 1365-2710. |
